- Kick-start for metabolomics in liver disease
- Browse: 254 Download: 744 Issue Date: 2024-09-23
- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 270 Download: 792 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 378 Download: 905 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 363 Download: 727 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 326 Download: 594 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 238 Download: 633 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 434 Download: 990 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 409 Download: 1174 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 392 Download: 856 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 388 Download: 914 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 415 Download: 853 Issue Date: 2024-07-26
- Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
- Browse: 372 Download: 953 Issue Date: 2024-06-27
- Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
- Browse: 311 Download: 1186 Issue Date: 2024-06-27
- Importance of the gut microbiota in the gut-liver axis in normal and liver disease
- Browse: 275 Download: 700 Issue Date: 2024-06-27
- Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
- Browse: 270 Download: 656 Issue Date: 2024-06-27
- Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
- Browse: 264 Download: 727 Issue Date: 2024-06-27
- Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease
- Browse: 370 Download: 1235 Issue Date: 2024-05-27
- Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis
- Browse: 371 Download: 959 Issue Date: 2024-05-27
- Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
- Browse: 279 Download: 723 Issue Date: 2024-05-27
- Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
- Browse: 307 Download: 765 Issue Date: 2024-05-27